Novel camelid antibody fragments targeting recombinant nucleoprotein of Araucaria hantavirus: A prototype for an early diagnosis of hantavirus pulmonary syndrome

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Pereira, Soraya S ^a   Moreira Dill, Leandro S ^a   Morais, Michelle S S ^a   Prado, Nidiane D R ^a   Barros, Marcos L ^a   Koishi, Andrea C ^a   Mazarrotto, Giovanny A C A ^a   Gonҫalves, Giselle M ^a   Zuliani, Juliana P ^a,b   Calderon, Leonardo A ^a,b   Soares, Andreimar M ^a   Pereira Da Silva, Luiz H ^a   Duarte Dos Santos, Claudia N ^a   Fernandes, Carla F C ^a,c   Stabeli, Rodrigo G ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSIDADE FEDERAL DE RONDÔNIA   (Brazil)

^c CEPEM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COAT PROTEIN; COAT PROTEIN III; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VHH ANTIBODY; VIRUS NUCLEOPROTEIN; IMMUNOGLOBULIN FRAGMENT; NUCLEOPROTEIN; VIRUS ANTIBODY;

ADULT; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; ARTIODACTYLA; AURACARIA HANTAVIRUS; CLONE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HANTAVIRUS; IMMUNIZATION; LAMA GLAMA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PROTEIN IMMOBILIZATION; SURFACE PLASMON RESONANCE; WESTERN BLOTTING; YOUNG ADULT; ANIMAL; BIOSYNTHESIS; CAMEL; CHEMISTRY; EARLY DIAGNOSIS; HANTAVIRUS PULMONARY SYNDROME; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; SEQUENCE HOMOLOGY;

ARAUCARIA; CAMELIDAE; HANTAVIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CAMELS; EARLY DIAGNOSIS; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MALE; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SURFACE PLASMON RESONANCE;

EID: 84907916532     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108067     Document Type: Article

References (61)

1. Ducancel F, Muller BH (2012) Molecular engineering of antibodies for therapeutic and diagnostic purposes. MAbs 4: 445-57.
2. Saerens D, Huang L, Bonroy K, Muyldermans S (2008) Antibody Fragments as Probe in Biosensor Development. Sensors 8: 4669-4686.
3. Vincke C, Loris R, Saerens D, Martinez-Rodriguez S, Muyldermans S, et al. (2009) General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J Biol Chem 284: 3273-84.
4. Muyldermans S (2013) Nanobodies: Natural Single-Domain Antibodies. Annu Rev Biochem 82: 775-797.
5. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, et al. (1993) Naturally occurring antibodies devoid of light chains. Nature 363: 446-448.
6. Conrath KE, Wernery U, Muyldermans S, Nguyen VK (2003) Emergence and evolution of functional heavy-chain antibodies in Camelidae. Dev Comp Immunol 27: 87-103.
7. Harmsen M, De Haard H (2007) Properties, production, and applications of camelid single-domain antibody fragments. Appl Microb Biotechnol 77: 13-22.
8. Muyldermans S (2001) Single domain camel antibodies: current status. J Biotechnol 74: 277-302.
9. Ghahroudi MA, Desmyter A, Wyns L, Hamers R, Muyldermans S (1997) Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 414: 521-26.
10. Nguyen VK, Su C, Muyldermans S, Van der Loo W (2002) Heavy-chain antibodies in Camelidae; a case of evolutionary innovation. Immunogenetics 54: 39-47.
11. Olichon A, Surrey T (2007) Selection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coli. J Biol Chem 282: 36314-20.
12. Hultberg A, Temperton NJ, Rosseels V, Koenders M, Gonzalez-Pajuelo M, et al. (2011) Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules. PLoS ONE 6: e17665.
13. Saerens D, Ghassabeh GH, Muyldermans S (2008) Single-domain antibodies as building blocks for novel therapeutics. Curr Opin Pharmacol 8: 600-608.
14. Strokappe N, Szynol A, Aasa-Chapman M, Gorlani A, Quigley AF, et al. (2012) Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C. PLoS ONE 7: e33298.
15. Thys B, Schotte L, Muyldermans S, Wernery U, Hassanzadeh-Ghassabeh G, et al. (2010) In vitro antiviral activity of single domain antibody fragments against poliovirus. Antiviral Res 87: 257-64.
16. van der Vaart JM, Wolvers D, Bezemer S, Hermans PW, Bellamy K, et al. (2006) Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments. Vaccine 24: 4130-4137.
17. Koh WWL, Steffensen S, Gonzalez-Pajuelo M, Hoorelbeke B, Gorlani A, et al. (2010) Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1. J Biol Chem 285: 19116-24.
18. Goldman ER, Anderson GP, Liu JL, Delehanty JB, Sherwood LJ, et al. (2006) Facile generation of heatstable antiviral and antitoxin single domain antibodies from a semisynthetic llama library. Anal Chem 78: 8245-55.
19. Sherwood LJ, Osborn LE, Carrion R Jr, Patterson JL, Hayhurst A (2007) Rapid Assembly of Sensitive Antigen-Capture Assays for Marburg Virus, Using In Vitro Selection of Llama Single-Domain Antibodies, at Biosafety Level 4. J Infect Dis 196: S213-9.
20. Schmaljohn C, Hjelle B (1997) Hantaviruses: a global disease problem. Emerg Infect Dis 3: 95-104.
21. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, et al. (1993) Genetic identification of a novel Hantavírus associated with na outbreak of acute respiratory illness in the soutwestern Unites States. Science 262: 914-917.
22. CDC (2012) U.S. HPS cases, by state of exposure. Available: http://www.cdc.gov/hantavirus/surveillance/state-of-exposure. Accessed 13 May 2013.
23. Brazilian Ministry of Healty (2012) Available: http://portal.saude.gov.br/portal/saude/profissional/area.cfm?id-area=1558. Accessed 13 May 2013.
24. Raboni SM, Levis S, Rosa ES, Bisordi I, Delfraro A, et al. (2007) Hantavirus infection in Brazil: development and evaluation of an enzyme immunoassay and immunoblotting based on N recombinant protein. Diagn Microbiol Infect Dis 58: 89-97.
25. Raboni SM, Probst CM, Bordignon J, Zeferino A, dos Santos CN (2005) Hantaviruses in Central South America: phylogenetic analysis of the S segment from HPS cases in Paraná, Brazil. J Med Virol 76: 553-62.
26. Zöller LG, Yang S, Gött P, Bautz EK, Darai G (1993) A novel mu-capture enzymelinkedimmunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome. J Clin Microbiol 31: 1194-1199.
27. Mazzarotto GA, Raboni SM, Stella V, Carstensen S, de Noronha L, et al. (2009) Production and characterization of monoclonal antibodies against the recombinant nucleoprotein of Araucaria hantavirus. J Virol Methods 162: 96-100.
28. Elgh F, Lundkvist A, Alexeyev OA, Wadell G, Juto P (1996) A major antigenic domain fot the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus. J Virol Methods 59: 161-172.
29. Gött P, Zöller L, Darai G, Bautz EK (1997) A major antigenic domain of hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein. Virus Genes 14: 31-40.
30. Lundkvist A, Scholander C, Niklasson B (1993) Anti-idiotypic antibodies against Puumala virus glycoprotein-specific monoclonal antibodies inhibit virus infection in cell culture. ArchVirol 132: 255-265.
31. Schmidt J, Jandrig B, Klempa B, Yoshimatsu K, Arikawa J, et al. (2005) Nucleocapsid protein of cell cultureadapted Seoul virus strain 80-39: analysis of its enconding sequence, expression in yeast and immuno-reactivity. Virus Genes 30: 37-48.
32. Li J, Zhang Q, Wang T, Li C, Liang M, et al. (2010) Tracking hantavirus nucleocapsid protein using intracellular antibodies. Virol J 7: 339.
33. Plyusnin A, Vapalahti O, Vaheri A (1996) Hantaviruse: genome, structure, expression and evolution. J Gen Virol 77: 2677-2687.
34. Raboni SM, Delfraro A, Borba L, Teixeira BR, Stella V, et al. (2012) Hantavirus Infection Prevalence in Wild Rodents and Human Anti-Hantavirus Serological Profiles from Different Geographic Areas of South Brazil. Am J Trop Med Hyg 87: 371-378.
35. Kent UM (1994) Purification of antibodies using ammonium sulfate fractionation or gel filtration. Methods Mol Biol. 34: 13-21.
36. Lubega GW, Byarugaba DK, Prichard RK (2002) Immunization with a tubulin-rich preparation from Trypanosoma brucei confers broad protection against African trypanosomosis. Exp Parasitol. 102(1):9-22.
37. Lafaye P, Achour I, England P, Duyckaerts C, Rougeon F (2009) Single-domain antibodies recognize selectively small oligomeric forms of amyloid β, prevent Aβ-induced neurotoxicity and inhibit fibril formation. Mol Immunol 46: 695-704.
38. Johnsson B, Löfa˚s S, Lindquist G (1991) Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem 198: 268-277.
39. Andersson K, Hämäläinen M, Malmqvist M (1999) Identification and Optimization of Regeneration Conditions for Affinity-Based Biosensor Assays. A Multivariate Cocktail Approach. Anal Chem 71: 2475-81.
40. Raboni SM, Rubio G, De Borba L, Zeferino A, Skraba I, et al. (2005) Clinical survey of hantavirus in Southern Brazil and the development of specific molecular diagnosis tools. Am. J. Trop. Med. Hyg. 72: 800-804.
41. Vincke C, Muyldermans S (2012) Introduction to heavy chain antibodies and derived Nanobodies. In: Saerens D, Muyldermans S editors. Single domain antibodies: methods and protocols. Humana Press. pp. 15-26.
42. Harmsen MM, van Solt CB, van Zijderveld-van Bemmel AM, Niewold TA, van Zijderveld FG (2006) Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy. Appl Microbiol Biotechnol 72: 544-51.
43. Nguyen VK, Hamers R, Wyns L, Muyldermans S (1999) Loss of splice consensus signal is responsible for the removal of the entire CH1 domain of the functional camel IgG2A heavy chain antibodies. Mol Immunol 36: 515-524.
44. Schoonooghe S, Laoui D, Van Ginderachter Ja, Devoogdt N, Lahoutte T, et al. (2012) Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancer. Immunobiology 217: 1266-72.
45. Dumoulin M, Conrath K, Van Meirhaeghe A, Meersman F, Heremans K, et al. (2002) Single-domain antibody fragments with high conformational stability. Protein Sci 11: 500-15.
46. Garaicoechea L, Olichon A, Marcoppido G, Wigdorovitz A, Mozgovoj M, et al. (2008) Protein Possess Broad Neutralizing Activity In Vitro and Confer Protection Llama-Derived Single-Chain Antibody Fragments Directed to Rotavirus VP6 Protein Possess Broad Neutralizing Activity In Vitro and Confer Protection against Diarrhea in Mice. J Virol 82: 9753-64.
47. Ruo SL, Sanchez A, Elliott LH, Brammer LS, McCormick JB, et al. (1991) Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Arch Virol 119: 1-11.
48. Chotwiwatthanakun C, Pratanaphon R, Akesowan S, Sriprapat S, Ratanabanangkoon K. (2001) Production of potente polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol. Toxicon 39(10):1487-94.
49. Richard G, Meyers AJ, McLean MD, Arbabi-Ghahroudi M, MacKenzie R, et al. (2013) In vivo neutralization of a-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody. PLoS One 8(7):e69495.
50. Kolkman JA, Law DA (2010) Nanobodies - from llamas to therapeutic proteins. Drug Discov Today Technol 7: 139-146.
51. Russel M, Model P (2006) Filamentous phage. In: Calendar R, editor. The Bacteriophages. Oxford: Oxford University Press, pp 146-160.
52. Muyldermans S, Atarhouch T, Saldanha J, Barbosa JA, Hamers R (1994) Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng 7: 1129-35.
53. Vu KB, Ghahroudi MA, Wyns L, Muyldermans S (1997) Comparison of llama VH sequences from conventional and heavy chain antibodies. Mol Immunol 34: 1121-31.
54. Rock EP, Sibbald PR, Davis MM, Chien YH (1994) CDR3 length in antigen-specific immune receptors. J Exp Med 179: 323-328.
55. Karlsson R, Michaelsson A, Mattsson L (1991) Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J Immunol Methods 145: 229-40.
56. Tanha J, Dubuc G, Hirama T, Narang SA, MacKenzie CR (2002) Selection by phage display of llama conventional V(H) fragments with heavy chain antibody V(H)H properties. J Immunol Methods 263: 97-109.
57. Doyle PJ, Arbabi-Ghahroudi M, Gaudette N, Furzer G, Savard ME, et al. (2008) Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivaleno. Mol Immunol 45: 3703-13.
58. Wang M, Rossi C, Schmaljohn CS (1993) Expression of non-conserved regions of the S genome segments of three hantaviruses: evaluation of the expressed polypeptides for diagnosis of haemorrhagic fever with renal syndrome. J Gen Virol 74: 1115-24.
59. Moreli ML (2005) Diagnosis by detection of hantavirus genomic and phylogenetic analysis with a recombinant protein production. University of Sao Paulo, Brazil.
60. Figueiredo LT, Moreli ML, Borges AA, Figueiredo GG, Souza RL, et al. (2008) Expression of a hantavírus N protein and its efficacy as antigen in immune assays. Braz J Med Biol Res 41: 596-9.
61. Wang CY, Zhang HH, Yu SL, Zhu CB (2007) Detection of circulating antigen with a MAb-based sandwich-ELISA and its comparison with specific IgM detection in sera of patients with hemorrhagic fever with renal syndrome. Hybridoma (Larchmt) 26: 42-5.